Therapy News and Research

RSS

Novel form of life-threatening skin disease identified using innovative diagnostic platform

A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no effective treatments beyond symptom management.

24 Feb 2025

Understanding the causes and symptoms of obstructive sleep apnea

Do you feel tired or have a headache when you wake up in the morning? Something might be going wrong while you sleep that you don't know about: obstructive sleep apnea (pronounced app-nee-uh).

24 Feb 2025

Study finds key p53 targets for future cancer treatment

A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells."

24 Feb 2025

Strontium-enhanced exosomes show promise for osteoarthritis treatment

Temporomandibular joint osteoarthritis (TMJOA) is a debilitating condition that causes severe joint pain, restricted mobility, and progressive cartilage degradation.

24 Feb 2025

Trump froze out project 2025 in his campaign. Now its blueprint is his health care playbook.

Few voters likely expected President Donald Trump in the first weeks of his administration to slash billions of dollars from the nation's premier federal cancer research agency.

24 Feb 2025

Study unravels the complex interplay of the UPS in cancer development and treatment

A new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study provides novel insights into how ubiquitination and deubiquitination impact tumor cells, immune responses, and potential therapeutic strategies for cancer treatment.

24 Feb 2025

Why over 5 billion people still lack access to life-saving medical oxygen

The Lancet Global Health Commission highlights severe inequities in medical oxygen access, urging systemic reforms to ensure universal availability and affordability.

23 Feb 2025

ETH Zurich team uncovers mechanism behind microbubble drug delivery

ETH Zurich researchers have investigated how tiny gas bubbles can deliver drugs into cells in a targeted manner using ultrasound.

22 Feb 2025

Study reveals gaps in palliative care for patients with advanced cancer

Despite considerable efforts to improve the quality of end-of-life care in the United States, a new retrospective study led by American Cancer Society (ACS) researchers revealed that close to half of patients with advanced cancer received potentially aggressive care at the end-of-life at the expense of supportive care.

22 Feb 2025

New photosensitizer shows promise in treating colorectal cancer

Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies have been employed for clinical CRC therapy.

22 Feb 2025

Development of lymphoma following CAR-T cell therapy

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

22 Feb 2025

New genetic medicine offers life-changing vision improvements for blind children

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute of Ophthalmology and Moorfields Eye Hospital, with the support of MeiraGTx.

22 Feb 2025

Study finds lack of consensus on how to treat chronic non-cancer pain

Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help some patients.

22 Feb 2025

Targeted mRNA therapy shows promise for healing damaged lungs

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

21 Feb 2025

FDA-approved devices used to treat cardiovascular diseases

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug Administration, such as pacemakers and defibrillators, have extended and improved the lives of millions of people living with heart disease.

21 Feb 2025